Overview

  • Product nameAnti-C6orf204 antibody
    See all C6orf204 primary antibodies
  • Description
    Rabbit polyclonal to C6orf204
  • Tested applicationsSuitable for: IHC-Pmore details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    antigen: LDCKYKFESC SKEDFRASSS TLRRQPVDMT YSALPESKPI MTSSEAFEPP KYLMLGQQAV GGVPIQPSVR TQMW, corresponding to amino acids 226-299 of Human C6orf204 according to Q5SZL2.

  • Positive control
    • Human liver tissue

Properties

Associated products

Applications

Our Abpromise guarantee covers the use of ab122039 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
IHC-P 1/20 - 1/50. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.

Target

  • Sequence similaritiesBelongs to the CEP85 family.
  • Cellular localizationCytoplasm > cytoskeleton > centrosome. Subcellular experiments using a GFP-taggedc system produced a weak signal, rendering difficult to confirm centrosome association.
  • Information by UniProt
  • Database links
  • Alternative names
    • bA57K17.2 antibody
    • C6orf204 antibody
    • centrosomal protein 85kDa-like antibody
    • CF204_HUMAN antibody
    • Coiled-coil domain-containing protein C6orf204 antibody
    • NY-BR-15 antibody
    • RP11-57K17.2 antibody
    • Serologically defined breast cancer antigen NY-BR-15 antibody
    see all

Anti-C6orf204 antibody images

  • ab122039, at 1/30, staining C6orf204 in paraffin embedded Human liver tissue by Immunohistochemistry.

References for Anti-C6orf204 antibody (ab122039)

ab122039 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab122039.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"